Alexandre Bleibtreu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alexandre Bleibtreu

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

The Lancet. Infectious Diseases|February 22, 2025

Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational studyAriane Gavaud, Matthieu Holub, Antoine Asquier-Khati, et al.

Antibiotics (Basel, Switzerland)|April 29, 2025

Real-Life Cefiderocol Use in Bone and Joint Infection: A French National CohortAva Diarra, Maxime Degrendel, Isabelle Eberl, et al.

Antibiotics (Basel, Switzerland)|January 8, 2025

National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for <i>Pseudomonas aeruginosa</i>Aurélien Dinh, Alexandre Bleibtreu, Clara Duran, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

The Lancet. Infectious Diseases|February 22, 2025

Antibiotics (Basel, Switzerland)|April 29, 2025

Real-Life Cefiderocol Use in Bone and Joint Infection: A French National CohortAva Diarra, Maxime Degrendel, Isabelle Eberl, et al.

Antibiotics (Basel, Switzerland)|January 8, 2025

National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for <i>Pseudomonas aeruginosa</i>Aurélien Dinh, Alexandre Bleibtreu, Clara Duran, et al.

Pageof 7